ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

PTN Palatin Technologies Inc New

1.827
0.107 (6.22%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Palatin Technologies Inc New PTN AMEX 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.107 6.22% 1.827 09:00:00
개장가 저가 고가 종가 전일 종가
1.72 1.68 1.83 1.82 1.72
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/04/202420:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
08/03/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202402:57EDGAR2Form 144 - Report of proposed sale of securities
28/02/202421:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
15/02/202423:00EDGAR2Form 8-K - Current report
15/02/202421:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
15/02/202406:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/02/202404:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202421:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
05/02/202421:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
02/02/202407:16EDGAR2Form 8-K - Current report
02/02/202406:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
30/01/202422:00PRNUSPalatin Announces $10 Million Registered Direct Offering
09/01/202400:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
03/01/202422:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
20/12/202323:00EDGAR2Form 8-K - Current report
20/12/202321:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
19/12/202306:45EDGAR2Form 8-K - Current report
19/12/202306:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
18/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
09/12/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202307:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202304:25EDGAR2Form 144 - Report of proposed sale of securities
05/12/202307:00EDGAR2Form S-1 - General form for registration of securities under..
02/12/202305:52EDGAR2Form 144 - Report of proposed sale of securities
14/11/202321:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
09/11/202321:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
25/10/202305:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
25/10/202305:05EDGAR2Form 8-K - Current report
23/10/202320:30PRNUSPalatin Announces $5 Million Registered Direct Offering
19/10/202321:01EDGAR2Form 8-K - Current report
19/10/202320:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
18/10/202320:30PRNUSPalatin Announces Positive Preclinical Data Showing..
16/10/202320:30PRNUSPalatin Presents Data at the United European..
14/10/202305:31EDGAR2Form 8-K - Current report
14/10/202305:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
28/09/202321:02EDGAR2Form 8-K - Current report
28/09/202321:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/09/202320:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
23/09/202305:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
08/09/202321:00EDGAR2Form 8-K - Current report
08/09/202305:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
07/09/202321:49EDGAR2Form 8-K - Current report
07/09/202320:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
17/08/202310:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/08/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202321:15EDGAR2Form 8-K - Current report
10/08/202320:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
08/08/202321:00EDGAR2Form 8-K - Current report
08/08/202320:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..

최근 히스토리

Delayed Upgrade Clock